Coverage and payer policy
Assess whether a coverage restriction, exception pathway, or medical-necessity standard still matches the current claim state.
Evidence-State Intelligence for Healthcare Claims
Know whether a healthcare claim still holds — and prove it.
Your team makes decisions based on claims about drugs, devices, and therapies. Those claims depend on evidence that shifts between reviews. NextConsensus continuously measures whether your claims remain substantiated against the current evidence surface — and produces a source-traced audit trail so you can prove it.
View Sample Brief Request a Scoped Brief
Scoping is free. We confirm whether your question fits a brief before any commitment.
Why Now
Evidence moves. Most teams review episodically.
Trial data, safety signals, label updates, guideline revisions, and payer actions accumulate between scheduled reviews. By the time a committee convenes, the evidence has moved — the position they're confirming may already be obsolete.
What's at stake:
- A market-access claim used in payer conversations loses its evidence footing.
- A safety narrative the label no longer supports remains in promotional materials.
- A diligence memo underwrites an asset on assumptions already weakening.
- A formulary position confirmed by committee is stale before the next cycle begins.
NextConsensus closes that gap — continuously.
What You Receive
A source-traced brief, not a black-box summary.
Every brief tests whether a specific claim remains substantiated under the current evidence record. You get the decision readout, the evidence trail, the source diffs, the scoring rationale, and the re-review trigger — because the brief is produced by a reproducible pipeline, not an analyst's interpretation.
- What changed
New evidence, policy movement, clinical-practice shifts, guideline edits, or changes in public reference sources.
- What still holds
The strongest remaining support for the existing position, drawn from the source record.
- Where the claim is vulnerable
Assumptions, objections, exclusions, or evidence gaps that no longer hold up under the current record.
- What could change the conclusion
The evidence, safety signal, policy change, or consensus movement that would strengthen, weaken, or reverse the assessment.
- Whether the review threshold is crossed
A clear assessment for the current window: hold, monitor, prepare for review, or escalate with explicit limits.
Use Cases
Monitor claims, detect drift, document decisions.
Formulary and pathway review
Determine whether emerging evidence should affect placement, sequencing, restrictions, or re-review timing.
Market access and launch strategy
Identify when payer, guideline, or practice movement is changing the practical status of a claim.
Safety and regulatory monitoring
Evaluate whether an objection, signal, or language shift is becoming strong enough to require review.
Diligence and strategy
Test whether a thesis rests on consensus that is hardening, weakening, or still too fragile to support action.
How It Works
Every claim is scored across clinical, regulatory, access, and safety dimensions.
We map the evidence for your disputed claim across four dimensions — clinical truth, ratification, economic stake, and operational feasibility — using a reproducible pipeline that enforces temporal boundaries and produces a decision posture. The brief is one output. The durable asset is the scored evidence map.
Sourced through Refract, our open-source observation engine.
Test the process on one claim. No commitment.
Send the disputed claim, decision context, and review timeline. We confirm whether a brief is in scope.